OpenVSafe by OpenVAERS
Search V-safe

MKR-31406-62130

3 vaccinations 1 coded response 12 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
921 / CA
Registered
2021-02-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
MHC-14265-23274 Child or adolescent in my care · Female · 2022-06-26

Timeline

  1. 2021-02-04
    Registered in v-safe
  2. 2021-02-04
    Dose 1 — Moderna
  3. 2021-02-04
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-02-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-02-05
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-02-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-02-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-14
    Dose 2 — Moderna
  12. 2021-03-14
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-03-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  14. 2021-06-13
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-09-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-11-17
    Dose 3 — Moderna
  17. 2022-03-16
    Survey response — 12 months, dose 2
    MedDRA: Hypothyroidism — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Hypothyroid
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-03-16
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  19. 2022-03-17
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12021-02-04Moderna
22021-03-14Moderna
32021-11-17Moderna No

Call center

2 call center cases

1 successful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 11 — 12 months, dose 2

2022-03-16

Symptoms: Hypothyroid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHypothyroidism · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…